Ahmed Alanazi, Department Program Director at King Fahad Medical City, shared a post on X:
“ADCs are now reshaping the standard of care for metastatic Breast Cancer after great news yesterday and potential changing the 1st line therapy for HER-2, MBC and TNBC DB-09 and ASCENT-04 met there primary endpoints as 1st line therapy in MBC.
Waiting for ASCO25.”
